Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $21.7200 (2.55%) ($21.2500 - $21.8200) on Fri. May. 24, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.94% (three month average) | RSI | 32 | Latest Price | $21.7200(2.55%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -0.7% a day on average for past five trading days. | Weekly Trend | EDIT declines -6.3% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(63%) ARKG(60%) XBI(59%) IWO(58%) ARKK(56%) | Factors Impacting EDIT price | EDIT will decline at least -1.97% in a week (0% probabilities). VXX(-17%) VIXM(-7%) UUP(-6%) IFRA(-4%) TLT(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.97% (StdDev 3.94%) | Hourly BBV | 0 () | Intraday Trend | 2% | | | |
|
1 - 5 Day Possible Target | $8.42(-61.23%) | Resistance Level | $23.44 | 5 Day Moving Average | $21.87(-0.69%) | 10 Day Moving Average | $22.22(-2.25%) | 20 Day Moving Average | $23.44(-7.34%) | To recent high | -21.8% | To recent low | 5.3% | Market Cap | $1.349b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |